In a report released today, Leonid Timashev from RBC Capital maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report), ...

RBC Capital analyst Jon Arfstrom maintained a Hold rating on Columbia Banking System (COLB – Research Report) yesterday and set a price target ...

RBC Capital Markets analyst Rishi Jaluria increased the price target on Twilio stock (NYSE:TWLO) to $75 from the previous $50 ...

Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...

In a research report released Friday, Mr. Kornack adjusted his earnings expectations across the sector to reflect a higher ...

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...

Analyst John Aiken expresses confidence that efforts by EQB, the bank's parent, to overcome recent credit weakness will ...

Brokers' investment trust recommendations for 2025 have come later than last year, presumably thanks to the drama currently ...

Stocks in the oil-and-gas sector fared better than the broader European market in a downbeat end to the year, with the Stoxx Europe 600 Oil & Gas sector index down 0.1% in the fourth quarter compared ...

However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...

CF Industries Holdings, Inc. (CF) stock saw a decline, ending the day at $93.66 which represents a decrease of $-3.35 or -3.45% from the prior close of $97.01. The stock opened at $95.5 and touched a ...

$180,000 of RBC CAPITAL MARKETS LLC (FORMERLY REGISTERED AS ROYAL BANK OF CANADA) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on ...